Amarin Corp Plc (AMRN)

[couldbebetter]

Because AMRN stated they will pursue legal and regulatory solutions to
their generic problems, does anyone here care to opine on what a
"regulatory solution" could look like?

For example, if the FDA wanted to, could they simply remove the Marine
indications entirely from Vascepa so AMRN's CV indications would be
protected? Does anyone know if this could be done? Does the FDA have
such powers?

I know this has been asked before but I do not recall any answers. My
apologies is I happened to miss them. (If the FDA could give such a
solution they would probably wait until AMRN were owned by the "right"
BP.) (Kiwi, Yup! I had to throw that in...just for you.)